Lorenzo’s oil (Adrenoleukodystrophy)

Product Description

Many neurologists may never see a case of Xlinked adrenoleukodystrophy unless they attend a showing of Lorenzo’s oil (1992), documenting the Odone family attempting to develop a treatment for this rare condition. Lorenzo’s oil (4:1 glyceryl trioleate-glyceryl trierucate) reduces hexacosanoic acid levels, and following clinical trial has been recommended in asymptomatic boys with normal brain MRI results.